Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
American Journal of Hematology|January 13, 2012
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemiaAlessandra Carobbio, Guido Finazzi, Juergen Thiele, et al.Haematologica|April 5, 2015
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosisChristophe Desterke, Christophe Martinaud, Bernadette Guerton, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative NeoplasmsLorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp, et al.Blood|January 13, 2019
CDK6 coordinates <i>JAK2</i> <sup><i>V617F</i></sup> mutant MPN via NF-κB and apoptotic networksIris Z Uras, Barbara Maurer, Harini Nivarthi, et al.European Journal of Haematology|July 31, 2018
Recommendations for the diagnosis and treatment of patients with polycythaemia veraAntónia Hatalova, Jiri Schwarz, Mirjana Gotic, et al.The Lancet. Haematology|February 5, 2020
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension studyHeinz Gisslinger, Christoph Klade, Pencho Georgiev, et al.Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.American Journal of Hematology|December 23, 2011
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignanciesAna Puda, Jelena D Milosevic, Tiina Berg, et al.Blood|May 10, 2007
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panelAyalew Tefferi, Juergen Thiele, Attilio Orazi, et al.European Journal of Haematology|October 30, 2023
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational studyAlexandre Theocharides, Heinz Gisslinger, Valerio De Stefano, et al.Pageof 15